537 Views

Instructional Course

Instructional Course - Available with the Platinum and Silver packages or Individual Course Ticket

033IC - Refractory Overactive Bladder: How to Select 3rd-line Therapies and Optimize Outcomes

033IC - Refractory Overactive Bladder: How to Select 3rd-Line Therapies and Optimize Outcomes

Saturday, May 14, 2022

4:00 PM – 6:00 PM

Location: Room 204

Instructional Course Director(s)

Kathleen Chizuko Kobashi, MD

Chair, Department of Urology
Virginia Mason Medical Center

Instructional Course Faculty(s)

David Alan Ginsberg, MD

Professor of Urology
USC Institute of Urology
Sandip Prasan Vasavada, MD

Professor of Urology
Cleveland Clinic Glickman Urological Institute and Lerner College of Medicine

Learning Objectives:

Describe the various 3rd line therapies available to treat refractory overactive bladder (OAB) and be able to discuss the pros and cons of each of the 3rd line therapies available to treat refractory OAB.
Explain with the current data regarding outcomes of percutaneous tibial nerve stimulation (PTNS), onabotulinumtoxinA and sacral neuromodulation for treatment of refractory OAB.
Outline how to perform PTNS.
Report how to perform onabotunlinumtoxinA injections in the office or outpatient setting..
Review techniques in optimal lead placement for sacral neuromodulation, programming and troubleshooting.

Upon completion, participants will be familiar with 3rd line therapies available to treat refractory OAB, including the pros and cons of each option, the current data regarding outcomes to facilitate proper patient counseling and optimal techniques to maximize the success of the various therapies. The case-based format will provide real-world scenarios by which to learn about the implementation of successful 3rd line options. The course will provide some dedicated focus to tips and tricks regarding the technical aspects of these options and the logistical implementation of them into a busy practice.